Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome-A Late, but Wise Decision
Marcos Felipe Silva de Sá · Federação Brasileira das Sociedades de Ginecologia e Obstetrícia · 2019
A FEBRASGO e o Novo Ano
Acceso al recurso
Entrá al contenido desde la opción principal o elegí otra fuente disponible.
Acceso abierto disponible
Cómo citar
Elegí el formato que necesitás y copiá la referencia al portapapeles.
APA 7
Sá, M. F. S. D. (2019). Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome-A Late, but Wise Decision. https://doi.org/10.1055/s-0039-1685482
MLA
Sá, Marcos Felipe Silva de. "Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome-A Late, but Wise Decision." 2019. https://doi.org/10.1055/s-0039-1685482.
Chicago
Sá, Marcos Felipe Silva de. 2019. "Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome-A Late, but Wise Decision.". https://doi.org/10.1055/s-0039-1685482.
Harvard
Sá, M. F. S. D. 2019, Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome-A Late, but Wise Decision, Federação Brasileira das Sociedades de Ginecologia e Obstetrícia, available at: https://doi.org/10.1055/s-0039-1685482 [Accessed 3 Jul. 2026].
Detalles del recurso
Información bibliográfica útil para confirmar que se trata del material correcto.
- Título
- Widding the Use of Insulin Sensitizers to Patients with Polycystic Ovarian Syndrome-A Late, but Wise Decision
- Autor / colaboradores
- Marcos Felipe Silva de Sá
- Editorial
- Federação Brasileira das Sociedades de Ginecologia e Obstetrícia
- Año de publicación
- 2019
- ISSN
- 0100-7203
- ISSN
- 0100-7203
- Idioma
- eng